(Q48737138)

15 February 2018

title

Metastatic tumors of the nervous system. (English)

1 reference

15 February 2018

author name string

Sophie Taillibert

series ordinal

1

1 reference

15 February 2018

Jean-Yves Delattre

series ordinal

2

1 reference

15 February 2018

publication date

1 October 2005

1 reference

15 February 2018

Journal of Neuro-Oncology

published in

1 reference

15 February 2018

volume

75

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

1-3

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-004-8092-7

exact match

0 references

cites work

Wilms' Tumor in Adults: Results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-004-8092-7

Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment

21 January 2018

1 reference

12 December 2020

The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma

1 reference

12 December 2020

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

1 reference

12 December 2020

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

12 December 2020

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

12 December 2020

Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?

1 reference

12 December 2020

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer.

1 reference

12 December 2020

10.1007/S11060-004-8092-7

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018